Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects.

Ten normal subjects and ten patients with chronic renal failure requiring hemodialysis were given intravenous infusions of moxalactam ranging from 500 mg to 2 g. Serum and urine concentrations were measured for up to 12 h. Renal failure subjects were given doses both during and between hemodialysis...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Peterson, L R, Bean, B, Fasching, C E, Korchik, W P, Gerding, D N
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1981
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181704/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6458235/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.20.3.378
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!